Document Detail

Reduced metabolic rate during beta-adrenergic blockade in humans.
MedLine Citation:
PMID:  1650879     Owner:  NLM     Status:  MEDLINE    
We previously reported that 1 week of propranolol treatment (160 to 240 mg/d, orally) reduced resting metabolic rate (RMR) an average of 9% in healthy men. To determine whether this response was caused by the 25% reduction in serum triidothyronine (T3), rather than beta-adrenergic blockade, we examined the effect of nadolol on RMR in five healthy men. Nadolol is a nonselective beta-adrenergic antagonist that does not affect T3 production. After 6 to 10 days of nadolol treatment (240 mg/d), mean postabsorptive RMR declined 7% (P less than .01), with no significant change in serum T3 or thyroxine (T4) concentrations. This effect is significantly different from that of a hospitalized control group that received no drug and had no change in mean RMR, and was not different from the response to propranolol (previously published data). Nadolol slightly reduced the mean thermic response to a meal (12%), but this effect was not statistically significant. Mean postprandial RMR was 8% lower after nadolol treatment (P less than .01), mainly because of the reduced postabsorptive RMR, rather than a change in the response to the meal. These data suggest that beta-adrenergic activity makes a small but significant contribution to resting energy expenditure in man.
S Welle; R G Schwartz; M Statt
Related Documents :
20370949 - Use of propranolol to treat multicentric airway haemangioma.
6743479 - Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin.
2894439 - High capacity for pulmonary first-pass elimination of propranolol in rats.
6127889 - Clinical experiences with prenalterol as an antidote to beta-adrenoceptor blockade.
8049089 - Comparative analysis of electrophysiologic effect of metoprolol and disopyramide, actin...
7163739 - Parasympathetic and sympathetic influences on mucociliary activity in vivo.
10797849 - The effects of calcium channel blocker, flunarizine on spinal reflexes in the cats.
1937609 - Central hyperthermic effect of arsenic in rabbits.
9263399 - Bactericidal/permeability-increasing protein ameliorates hypercoagulability after hemor...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  40     ISSN:  0026-0495     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  1991 Jun 
Date Detail:
Created Date:  1991-09-10     Completed Date:  1991-09-10     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  619-22     Citation Subset:  IM    
Department of Medicine (Endocrine and Cardiology Units), University of Rochester School of Medicine and Dentistry, NY.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Basal Metabolism / drug effects*
Blood Pressure / drug effects*
Body Weight / drug effects
Nadolol / pharmacology*
Propranolol / pharmacology*
Pulse / drug effects*
Receptors, Adrenergic, beta / drug effects,  physiology
Thyroxine / blood
Triiodothyronine / blood
Grant Support
Reg. No./Substance:
0/Receptors, Adrenergic, beta; 42200-33-9/Nadolol; 525-66-6/Propranolol; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Leukotriene B4 promotes phospholipid acylation in human neutrophils.
Next Document:  Heat shock in Bacillus subtilis: genetic characterization of a mutant.